• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

Medical Devices: expected bottlenecks for certification

Karin Schulze, SFL’s Head of Medical Devices & Combination Products, was recently interviewed by AWP Finanznachrichten on the challenges for Notified Bodies who are currently in the designation process due to the upcoming Medical Devices and In Vitro Diagnostics Regulations (MDR and IVDR). Notably, she highlights the possibility that the first Notified Bodies will not be designated before mid-2019, resulting in bottlenecks for the whole industry. The adoption of stricter requirements for designation of Notified Bodies under the MDR and IVDR risks, therefore, to delay the market entry of medical devices,  thereby creating additional costs for manufacturers.

Read the full interview here (available in French only).

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top